However, our results find no tonic inhibition of CREB/ATF-mediated gene expression in leukocytes from untreated MDD patients versus control subjects, but rather indicate upregulation of CREB/ATF activity at baseline before treatment. This evidence concerns the gene CREB1 and major depressive disorder.